Hormone Research Market

Gonadorelin

A GnRH analogue tied to endocrine signaling, diagnostic history, and fertility-related peptide discussions.

GnRHEndocrineResearch Market

Also referenced as: Gonadotropin-Releasing Hormone, GnRH

Price compare
6 tracked offers across 6 vendors · 3 dosages
Best trust-adjusted value: Paramount Peptides · Light trust · $7.00/mg
From
$5.58/mg
Status
Research Market

This name primarily lives in the research market and should not be read like an approved pharmaceutical product.

Category
Hormone

This profile is grouped by its dominant research and market lane, not by vendor shelf placement.

Aliases
2

Gonadotropin-Releasing Hormone, GnRH

Signal depth
Medium

No FDA label signal · 150 trials · 295 PubMed results

Preclinical
Research evidence

Current evidence for Gonadorelin is limited to laboratory or animal studies — there are no name-matched human trials with reported results. Any claims about effects in people are not yet backed by clinical data.

Gonadorelin has no clinical trials that name it and 295 PubMed-indexed publications and is not FDA-approved. Current evidence is preclinical or mechanistic.

Human data
Lab / animal only
Trial quality
No human trials
Outcomes
No human trials
Replication
Multiple papers
Literature
Established
Theriogenology · 148 citations LH and FSH response of Holstein heifers to fertirelin acetate, gonadorelin and buserelin Pharmaceutical Research · 50 citations The Adjuvant Effect of Bacitracin on Nasal Absorption of Gonadorelin and Buserelin in Rats Theriogenology · 49 citations Comparison of gonadorelin products in lactating dairy cows: Efficacy based on induction of ovulation of an accessory follicle and circulating luteinizing hormone profiles Journal Article Recombinant bovine somatotropin at synchronization initiation, but not at embryo transfer, enhances fertility in embryo-recipient heifers: Associations with follicular, luteal, and embryonic outcomes. Case Reports Ovarian remnant syndrome in a 2-year-old cat with inconclusive diagnostics. Journal Article Effect of post-insemination GnRH analogue administration on pregnancy rates in repeat-breeder cows: comparison of dosage and frequency.
Evidence history

Re-checked nightly against the registries — tracked since 2026-07-09. No band changes yet.

Grades evidence strength, not efficacy or safety. Research-use context; not medical advice. Graded 2026-07-13 from PubMed, ClinicalTrials.gov, ISRCTN, openFDA, Health Canada, and OpenAlex — computed deterministically and refreshed nightly, with a retraction check. How we grade →

What gonadorelin is

Gonadorelin is a gonadotropin-releasing hormone analogue tied to reproductive endocrine signaling. It occupies a more medically grounded hormone lane than most retail-market peptides, even though it also shows up in vendor catalogs.

Why it matters

It helps round out the hormone category with a peptide centered on pituitary and reproductive signaling rather than growth hormone or cosmetic use.

Regulatory context

In the context of this library, gonadorelin should not be treated as a generic consumer peptide product. Human retail listings, veterinary products, and specialized medical use are not interchangeable categories.

Practical reading note

When a hormone peptide has real medical or diagnostic history, the safest move is to distinguish that history from the way it is repackaged in the research market.